The Impact of Semiautomatic Segmentation Methods on Metabolic Tumor Volume, Intensity, and Dissemination Radiomics in 18F-FDG PET Scans of Patients with Classical Hodgkin Lymphoma
- PMID: 34992152
- PMCID: PMC9454468
- DOI: 10.2967/jnumed.121.263067
The Impact of Semiautomatic Segmentation Methods on Metabolic Tumor Volume, Intensity, and Dissemination Radiomics in 18F-FDG PET Scans of Patients with Classical Hodgkin Lymphoma
Abstract
Consensus about a standard segmentation method to derive metabolic tumor volume (MTV) in classical Hodgkin lymphoma (cHL) is lacking, and it is unknown how different segmentation methods influence quantitative PET features. Therefore, we aimed to evaluate the delineation and completeness of lesion selection and the need for manual adaptation with different segmentation methods, and to assess the influence of segmentation methods on the prognostic value of MTV, intensity, and dissemination radiomics features in cHL patients. Methods: We analyzed a total of 105 18F-FDG PET/CT scans from patients with newly diagnosed (n = 35) and relapsed/refractory (n = 70) cHL with 6 segmentation methods: 2 fixed thresholds on SUV4.0 and SUV2.5, 2 relative methods of 41% of SUVmax (41max) and a contrast-corrected 50% of SUVpeak (A50P), and 2 combination majority vote (MV) methods (MV2, MV3). Segmentation quality was assessed by 2 reviewers on the basis of predefined quality criteria: completeness of selection, the need for manual adaptation, and delineation of lesion borders. Correlations and prognostic performance of resulting radiomics features were compared among the methods. Results: SUV4.0 required the least manual adaptation but tended to underestimate MTV and often missed small lesions with low 18F-FDG uptake. SUV2.5 most frequently included all lesions but required minor manual adaptations and generally overestimated MTV. In contrast, few lesions were missed when using 41max, A50P, MV2, and MV3, but these segmentation methods required extensive manual adaptation and overestimated MTV in most cases. MTV and dissemination features significantly differed among the methods. However, correlations among methods were high for MTV and most intensity and dissemination features. There were no significant differences in prognostic performance for all features among the methods. Conclusion: A high correlation existed between MTV, intensity, and most dissemination features derived with the different segmentation methods, and the prognostic performance is similar. Despite frequently missing small lesions with low 18F-FDG avidity, segmentation with a fixed threshold of SUV4.0 required the least manual adaptation, which is critical for future research and implementation in clinical practice. However, the importance of small, low 18F-FDG-avidity lesions should be addressed in a larger cohort of cHL patients.
Keywords: 18F-FDG PET/CT; Hodgkin lymphoma; outcome prediction; radiomics; segmentation methods.
© 2022 by the Society of Nuclear Medicine and Molecular Imaging.
Figures






Similar articles
-
Quantitative Radiomics Features in Diffuse Large B-Cell Lymphoma: Does Segmentation Method Matter?J Nucl Med. 2022 Mar;63(3):389-395. doi: 10.2967/jnumed.121.262117. Epub 2021 Jul 16. J Nucl Med. 2022. PMID: 34272315 Free PMC article.
-
Interobserver Agreement on Automated Metabolic Tumor Volume Measurements of Deauville Score 4 and 5 Lesions at Interim 18F-FDG PET in Diffuse Large B-Cell Lymphoma.J Nucl Med. 2021 Nov;62(11):1531-1536. doi: 10.2967/jnumed.120.258673. Epub 2021 Mar 5. J Nucl Med. 2021. PMID: 33674403 Free PMC article.
-
Automated Segmentation of Baseline Metabolic Total Tumor Burden in Diffuse Large B-Cell Lymphoma: Which Method Is Most Successful? A Study on Behalf of the PETRA Consortium.J Nucl Med. 2021 Mar;62(3):332-337. doi: 10.2967/jnumed.119.238923. Epub 2020 Jul 17. J Nucl Med. 2021. PMID: 32680929 Free PMC article.
-
Methodological Aspects and the Prognostic Value of Metabolic Tumor Volume assessed with 18F-FDG PET/CT in Lymphomas.Curr Radiopharm. 2022;15(4):259-270. doi: 10.2174/1874471015666220329120631. Curr Radiopharm. 2022. PMID: 35352655 Review.
-
The value of FDG PET/CT imaging in outcome prediction and response assessment of lymphoma patients treated with immunotherapy: a meta-analysis and systematic review.Eur J Nucl Med Mol Imaging. 2022 Nov;49(13):4661-4676. doi: 10.1007/s00259-022-05918-2. Epub 2022 Aug 6. Eur J Nucl Med Mol Imaging. 2022. PMID: 35932329 Free PMC article.
Cited by
-
The value of radiomics based on 2-[18 F]FDG PET/CT in predicting WHO/ISUP grade of clear cell renal cell carcinoma.EJNMMI Res. 2024 Nov 21;14(1):115. doi: 10.1186/s13550-024-01182-7. EJNMMI Res. 2024. PMID: 39570474 Free PMC article.
-
Semi-automated 18F-FDG PET segmentation methods for tumor volume determination in Non-Hodgkin lymphoma patients: a literature review, implementation and multi-threshold evaluation.Comput Struct Biotechnol J. 2023 Jan 20;21:1102-1114. doi: 10.1016/j.csbj.2023.01.023. eCollection 2023. Comput Struct Biotechnol J. 2023. PMID: 36789266 Free PMC article.
-
Quantitative PET-based biomarkers in lymphoma: getting ready for primetime.Nat Rev Clin Oncol. 2023 Sep;20(9):640-657. doi: 10.1038/s41571-023-00799-2. Epub 2023 Jul 17. Nat Rev Clin Oncol. 2023. PMID: 37460635 Review.
-
Advances in positron emission tomography and radiomics.Hematol Oncol. 2023 Jun;41 Suppl 1(Suppl 1):11-19. doi: 10.1002/hon.3137. Hematol Oncol. 2023. PMID: 37294959 Free PMC article. Review.
-
Baseline 18F-FDG PET/CT Radiomics in Classical Hodgkin's Lymphoma: The Predictive Role of the Largest and the Hottest Lesions.Diagnostics (Basel). 2023 Apr 11;13(8):1391. doi: 10.3390/diagnostics13081391. Diagnostics (Basel). 2023. PMID: 37189492 Free PMC article.
References
-
- Albano D, Mazzoletti A, Spallino M, et al. . Prognostic role of baseline 18F-FDG PET/CT metabolic parameters in elderly HL: a two-center experience in 123 patients. Ann Hematol. 2020;99:1321–1330. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical